Open Access

Anti‑carcinogenic activity of anandamide on human glioma in vitro and in vivo

  • Authors:
    • Chao Ma
    • Ting‑Ting Wu
    • Pu‑Cha Jiang
    • Zhi‑Qiang Li
    • Xin‑Jun Chen
    • Kai Fu
    • Wei Wang
    • Rui Gong
  • View Affiliations

  • Published online on: December 28, 2015     https://doi.org/10.3892/mmr.2015.4721
  • Pages: 1558-1562
  • Copyright: © Ma et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

The poor prognosis of gliomas is to a large extent attributed to the markedly proliferative and invasive nature of the disease. Endocannabinoids have emerged as novel potential anti‑tumor agents. The present study aimed to investigate the anti‑carcinogenic activity of anandamide (AEA), an endocannabinoid, on glioma cells. To assess the functional role of AEA in glioma, the effects of AEA on cell proliferation, migration, invasion, apoptosis and the cell cycle in vitro, and tumor growth in vivo, were investigated. AEA markedly inhibited the proliferation of U251 cells in a dose‑ and time‑dependent manner. Flow cytometric assays revealed that the apoptosis rate of U251 cells upon treatment with AEA was increased. AEA also suppressed the adhesion, migration and invasion capabilities of the U251 cells. Furthermore, AEA inhibited tumor growth in vivo. These results highlighted the potential role of AEA in the tumorigenesis and progression of glioma, and suggested that AEA exhibits therapeutic potential in the management of human glioma.

References

1 

Takahashi S, Hirose Y, Ikeda E, Fukaya R and Kawase T: Chromosome arm 1q gain associated with good response to chemotherapy in a malignant glioma. Case report. J Neurosurg. 106:488–494. 2007. View Article : Google Scholar : PubMed/NCBI

2 

Takahashi S, Yamada-Okabe H, Hamada K, Ohta S, Kawase T, Yoshida K and Toda M: Downregulation of uPARAP mediates cytoskeletal rearrangements and decreases invasion and migration properties in glioma cells. J Neurooncol. 103:267–276. 2011. View Article : Google Scholar

3 

Hernán Pérez de la Ossa D, Gil-Alegre ME, Ligresti A, Aberturas Mdel R, Molpeceres J, Torres AI and Di Marzo V: Preparation and characterization of Δ(9)-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines. J Drug Target. 21:710–718. 2013. View Article : Google Scholar

4 

Caffarel MM, Andradas C, Pérez-Gómez E, Guzmán M and Sánchez C: Cannabinoids: A new hope for breast cancer therapy? Cancer Treat Rev. 38:911–918. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Velasco G, Sánchez C and Guzmán M: Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 12:436–444. 2012. View Article : Google Scholar : PubMed/NCBI

6 

Sánchez C, Galve-Roperh I, Canova C, Brachet P and Guzmán M: Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett. 436:6–10. 1998. View Article : Google Scholar : PubMed/NCBI

7 

Di Marzo V and De Petrocellis L: Why do cannabinoid receptors have more than one endogenous ligand? Philos Trans R Soc Lond B Biol Sci. 367:3216–3228. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Bosier B, Muccioli GG, Hermans E and Lambert DM: Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities. Biochem Pharmacol. 80:1–12. 2010. View Article : Google Scholar : PubMed/NCBI

9 

Mechoulam R and Hanus L: A historical overview of chemical research on cannabinoids. Chem Phys Lipids. 108:1–13. 2000. View Article : Google Scholar : PubMed/NCBI

10 

Pisanti S, Borselli C, Oliviero O, Laezza C, Gazzerro P and Bifulco M: Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor-suppressor efficacy. J Cell Physiol. 211:495–503. 2007. View Article : Google Scholar

11 

Miyato H, Kitayama J, Yamashita H, Souma D, Asakage M, Yamada J and Nagawa H: Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines. J Surg Res. 155:40–47. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Linsalata M, Notarnicola M, Tutino V, Bifulco M, Santoro A, Laezza C, Messa C, Orlando A and Caruso MG: Effects of anandamide on polyamine levels and cell growth in human colon cancer cells. Anticancer Res. 30:2583–2589. 2010.PubMed/NCBI

13 

Xie C, Liu G, Liu J, Huang Z, Wang F, Lei X, Wu X, Huang S, Zhong D and Xu X: Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells. Oncol Lett. 4:403–407. 2012.PubMed/NCBI

14 

Fride E: The endocannabinoid-CB receptor system: Importance for development and in pediatric disease. Neuro Endocrinol Lett. 25:24–30. 2004.PubMed/NCBI

15 

Patsos HA, Hicks DJ, Greenhough A, Williams AC and Paraskeva C: Cannabinoids and cancer: Potential for colorectal cancer therapy. Biochem Soc Trans. 33:712–714. 2005. View Article : Google Scholar : PubMed/NCBI

16 

Maccarrone M and Finazzi-Agró A: The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ. 10:946–955. 2003. View Article : Google Scholar : PubMed/NCBI

17 

Melck D, De Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M and Di Marzo V: Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology. 141:118–126. 2000.

18 

Galve-Roperh I, Sánchez C, Cortés ML, Gómez del Pulgar T, Izquierdo M and Guzmán M: Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med. 6:313–319. 2000. View Article : Google Scholar : PubMed/NCBI

19 

Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD and Davis JB: The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol. 129:227–230. 2000. View Article : Google Scholar : PubMed/NCBI

20 

Al-Hayani A, Wease KN, Ross RA, Pertwee RG and Davies SN: The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology. 41:1000–1005. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Tóth A, Blumberg PM and Boczán J: Anandamide and the vanilloid receptor (TRPV1). Vitam Horm. 81:389–419. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Maccarrone M, Lorenzon T, Bari M, Melino G and Finazzi-Agro A: Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J Biol Chem. 275:31938–31945. 2000. View Article : Google Scholar : PubMed/NCBI

23 

Zhang X, Zhang W, Mao XG, Zhen HN, Cao WD and Hu SJ: Targeting role of glioma stem cells for glioblastoma multiforme. Curr Med Chem. 20:1974–1984. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Grimaldi C, Pisanti S, Laezza C, Malfitano AM, Santoro A, Vitale M, Caruso MG, Notarnicola M, Iacuzzo I, Portella G, et al: Anandamide inhibits adhesion and migration of breast cancer cells. Exp Cell Res. 312:363–373. 2006. View Article : Google Scholar

25 

Zhao X and Guan JL: Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev. 63:610–615. 2011. View Article : Google Scholar :

26 

Golubovskaya VM and Cance WG: Focal adhesion kinase and p53 signaling in cancer cells. Int Rev Cytol. 263:103–153. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

February 2016
Volume 13 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Ma, C., Wu, T., Jiang, P., Li, Z., Chen, X., Fu, K. ... Gong, R. (2016). Anti‑carcinogenic activity of anandamide on human glioma in vitro and in vivo. Molecular Medicine Reports, 13, 1558-1562. https://doi.org/10.3892/mmr.2015.4721
MLA
Ma, C., Wu, T., Jiang, P., Li, Z., Chen, X., Fu, K., Wang, W., Gong, R."Anti‑carcinogenic activity of anandamide on human glioma in vitro and in vivo". Molecular Medicine Reports 13.2 (2016): 1558-1562.
Chicago
Ma, C., Wu, T., Jiang, P., Li, Z., Chen, X., Fu, K., Wang, W., Gong, R."Anti‑carcinogenic activity of anandamide on human glioma in vitro and in vivo". Molecular Medicine Reports 13, no. 2 (2016): 1558-1562. https://doi.org/10.3892/mmr.2015.4721